Latest News for: Pharmaceutical sources

Edit

Global Pharmaceutical Collaborative Robots Market Report 2023: A $140+ Market by 2030 - Surging Demand ...

The Eagle-Tribune 28 Nov 2023
The "Pharmaceutical Collaborative Robots Market Size, Share & Trends Analysis Report By Application (Picking & Packaging, Laboratory Applications), By End-use (Pharmaceutical Companies, Research Laboratories), And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering ... 5.2.1 Pharmaceutical Companies.
Edit

Seek Labs Announces Completion of Office Expansion to Support Business Growth

Maryville Daily Forum 28 Nov 2023
Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and pharmaceuticals, today announced the successful completion of a significant expansion at its headquarters ... New state-of-the-art laboratory spaces were added, which are intended for ongoing pharmaceutical research ... SOURCE.
Edit

Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as Chief Medical Officer

Maryville Daily Forum 28 Nov 2023
Amylyx Pharmaceuticals, Inc ... Bedrosian brings nearly 30 years of experience addressing unmet medical needs for people with rare and serious diseases through successful clinical and translational research programs, including as CMO at Ultragenyx Pharmaceutical Inc. (“Ultragenyx”), Alexion Pharmaceuticals, Inc ... as well as Rhythm Pharmaceuticals, Inc.
Edit

n-Lorem Unveils Limited Edition Holiday Ornament to Support its Mission to Provide Optimized ASO Therapies ...

The Joplin Globe 28 Nov 2023
Crooke, M.D., Ph.D., former chairman and CEO of Ionis Pharmaceuticals, who founded Ionis Pharmaceuticals in 1989 and, through his vision and leadership, established the company as the leader in RNA-targeted therapeutics ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20231128025166/en/ ... SOURCE.
Edit

Three New Articles in the Journal of Pharmaceutical Analysis Demonstrate the Potential of Natural Compounds ...

Victoria Advocate 28 Nov 2023
The latest issue of the�Journal of Pharmaceutical Analysis (JPA) features three articles that report promising findings and could pave the way to treatments for complex diseases affecting the liver and intestine.� ... Journal of Pharmaceutical Analysis ... SOURCE Journal of Pharmaceutical Analysis.
Edit

Derm-Biome Pharmaceuticals Announces Collaboration with Massachusetts General Hospital in Skin ...

Enid News & Eagle 28 Nov 2023
28, 2023 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver based biopharmaceutical company with a focus on skin disease, is excited to announce that it is collaborating with Dr ... surgeries (source ... About Derm-Biome Pharmaceuticals, Inc. Derm-Biome Pharmaceuticals, Inc.
Edit

Global Multiomics (Single-cell, Bulk) Market Research 2023-2030: Decreasing Costs and Growing Investments from Private/Public Sectors ...

The Eagle-Tribune 28 Nov 2023
In addition, rising competition in the market owing to increasing demand from pharmaceutical & biotechnology companies and academic research institutions is also anticipated to propel the market growth over the forecast period ... Pharmaceutical & Biotechnology Companies ... BIOTECHNOLOGY PHARMACEUTICAL HEALTH. SOURCE.
Edit

FDA Agrees Loyal Data Supports Reasonable Expectation of Effectiveness for Large Dog Lifespan Extension

Hastings Tribune 28 Nov 2023
LOY-001 represents a new category of pharmaceutical, focused on targeting mechanisms of aging to prevent or delay the onset of age-associated diseases, rather than waiting for patients to get sick before treating them ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20231127326868/en/ ... SOURCE.
Edit

Merck Announces First-Quarter 2024 Dividend

Enid News & Eagle 28 Nov 2023
View source version on businesswire.com.https.//www.businesswire.com/news/home/20231128981881/en/ ... HEALTH OTHER HEALTH CLINICAL TRIALS GENERAL HEALTH PHARMACEUTICAL BIOTECHNOLOGY. SOURCE.
Edit

BioMarin Announces Agreement with German Health Insurance Fund on Reimbursement Amount for ROCTAVIAN® (valoctocogene roxaparvovec-rvox) ...

Victoria Advocate 28 Nov 2023
28, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc ... In the event that any malignancy occurs after treatment with ROCTAVIAN, contact BioMarin Pharmaceutical Inc ... This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc ... BioMarin Pharmaceutical Inc ... SOURCE BioMarin Pharmaceutical Inc.
Edit

ATCC Announces Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) Award from NIAID

Maryville Daily Forum 28 Nov 2023
Products, such as Active Pharmaceutical Ingredients (APIs) and/or formulations, pathogens, specimens, and reagents, will be stored and available for shipping to laboratories, contractors, and product sponsors working to advance promising candidates from the laboratory to the clinic ... SOURCE.
Edit

CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; ...

Hastings Tribune 28 Nov 2023
MENLO PARK, Calif.--(BUSINESS WIRE)--Nov 27, 2023--. On November 20, 2023, CohBar, Inc ... Thereafter, Nasdaq will file a Form 25-NSE with the SEC to formally delist the Company’s common stock ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20231127359445/en/. Craig R ... KEYWORD ... BIOTECHNOLOGY PHARMACEUTICAL HEALTH. SOURCE ... PUB ... .
Edit

Obatala Sciences Announces Commercial Launch of Its ObaCell® Obesity-on-a-Chip Service

Hastings Tribune 28 Nov 2023
Founded in 2017 with the goal of advancing research in the fields of obesity, diabetes and regenerative medicine, Obatala Sciences is a biotechnology company that offers research products and services to scientists in the pharmaceutical industry and academia ... View source ... SOURCE.
Edit

KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023

The Eagle-Tribune 28 Nov 2023
MAHWAH, N.J.--(BUSINESS WIRE)--Nov 28, 2023--. KORU Medical Systems, Inc. (NASDAQ ... to 12.00 p.m. Eastern Time ... In-person attendance for the event requires advanced registration ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20231128260743/en/ ... MEDICAL DEVICES HEALTH PHARMACEUTICAL HEALTH TECHNOLOGY MEDICAL SUPPLIES. SOURCE.
Edit

Aro Biotherapeutics Secures $41.5M Series B Financing

The Eagle-Tribune 28 Nov 2023
PHILADELPHIA--(BUSINESS WIRE)--Nov 28, 2023-- ... (JJDC), Northpond Ventures, Healthcap and BVF Partners, L.P ... About ABX1100 ... About Aro Biotherapeutics ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20231128072316/en/. CONTACT. Mike Beyer. Sam Brown Inc ... FDA HEALTH GENETICS CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY. SOURCE ... .

Most Viewed

This handout photo provided by the Uttarakhand State Department of Information and Public Relations shows Pushkar Singh Dhami, right, Chief Minister of the state of Uttarakhand, greeting a worker rescued from the site of an under-construction road tunnel that collapsed in Silkyara in the northern Indian state of Uttarakhand, India, Tuesday, Nov. 28, 2023
AP / Uttarakhand State Department of Information and Public Relations
In this photo released by Uzbekistan's President Press Office, Iran's President Ebrahim Raisi attends the Summit of the Economic Cooperation Organisation (ECO) in Tashkent, Uzbekistan, on Thursday, Nov. 9, 2023
AP / Uzbekistan's President Press Office
×